Mirtazapine
Mostrando 1-12 de 14 artigos, teses e dissertações.
-
1. Sweet syndrome-like cutaneous drug reaction
Abstract: Cutaneous drug reactions are adverse reactions to medications that may present with different clinical features, ranging from localized to generalized lesions. In this report we describe a case of an unusual drug reaction, resembling the morphology of Sweet syndrome lesions. The patient had a psychiatric illness and was using thioridazine hydrochlo
An. Bras. Dermatol.. Publicado em: 2017-12
-
2. Chronic dosing with mirtazapine does not produce sedation in rats
Objective: Sedation/somnolence are major side effects of pharmacotherapies for depression, and negatively affect long-term treatment compliance in depressed patients. Use of mirtazapine (MIR), an atypical antidepressant approved for the treatment of moderate to severe depression with comorbid anxiety disorders, is associated with significant sedation/somnol
Rev. Bras. Psiquiatr.. Publicado em: 23/03/2017
-
3. Antidepressivos modificam a extinção de uma memória aversiva em ratas
Treatment of major depression, posttraumatic stress disorder and other psychopathologies with antidepressants can be associated with improvement of the cognitive deficits related to these disorders. Although the mechanisms of these effects are not completely elucidated, alterations in extinction of aversive memories are believed to be present in these psycho
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 16/05/2011
-
4. Mirtazapine versus fluoxetine in the treatment of panic disorder
Mirtazapine is an antidepressant whose side effect profile differs from that of first-line agents (selective serotonin reuptake inhibitors) used in the treatment of panic disorder. The present study compared the effect of mirtazapine and fluoxetine in the treatment of panic disorder in a double-blind, randomized, flexible-dose trial conducted with outpatient
Publicado em: 2010
-
5. Desenvolvimento das barras imunosorventes de agitação e avaliação das técnicas extração sortiva em barra de agitação, microextração em sorvente empacotado e cromatografia líquida para análise de antidepressivos em amostras de plasma / Development of immunosorbent stir bars and evaluation of stir bar sorptive extraction, microextraction by packed sorbent and liquid chromatography for the analysis of antidepressants in plasma samples
In this work, polyclonal and monoclonal anti-fluoxetine antibodies were developed in rabbits and mice by immunization with fluoxetine-bovine albumin conjugate, respectively. The developed antibodies were characterized on the basis of the specificity against the drug by ELISA (enzyme linked immunosorbent assay) and, subsequently they were purified by labmade
Publicado em: 2010
-
6. Análise enantiosseletiva da mirtazapina e seus metabólitos: técnicas modernas de microextração e análise e aplicação em estudos de disposição cinética / Enantioselective analysis of mirtazapine and its metabolites: modern techniques for microxtraction and analysis and application to kinetic disposition studies
A necessidade de metodologias adequadas para análise de fármacos e seus metabólitos em matrizes biológicas complexas levaram a um crescente interesse no desenvolvimento de novas técnicas de preparação de amostras, particularmente as técnicas de microextração, por serem altamente seletivas e requererem o consumo mínimo de solventes orgânicos. Alia
Publicado em: 2008
-
7. Análise enantiosseletiva da mirtazapina em plasma: comparação de métodos de preparação das amostras / Enantioselective analysis of plasma mirtazapine: comparison of sample preparation methods
The increased interest in enantioselective pharmacokinetic and pharmacodynamic properties of chiral drugs, aiming to establish the advantages in the production of estereochemically pure drugs, has led to the development of methods of analysis with low limits of quantification, selectivity and reproducibility, which are suitable to be used in kinetic disposit
Publicado em: 2005
-
8. Mirtazapine versus fluoxetine in the treatment of panic disorder
Mirtazapine is an antidepressant whose side effect profile differs from that of first-line agents (selective serotonin reuptake inhibitors) used in the treatment of panic disorder. The present study compared the effect of mirtazapine and fluoxetine in the treatment of panic disorder in a double-blind, randomized, flexible-dose trial conducted with outpatient
Brazilian Journal of Medical and Biological Research. Publicado em: 2001-10
-
9. A Trilogy Case Review Highlighting the Clinical and Pharmacologic Applications of Mirtazapine in Reducing Polypharmacy for Anxiety, Agitation, Insomnia, Depression, and Sexual Dysfunction
Background: Mirtazapine, a noradrenergic and specific serotonergic antidepressant (NaSSA), is characterized by a unique receptor-specific pharmacologic profile and tolerable side-effect profile in comparison to other antidepressants. It has been reported to have a low incidence of agitation, anxiety, and insomnia, which may be due to blockade of 5-HT2 and 5-
Physicians Postgraduate Press.
-
10. Panic Attacks During Escalation of Mirtazapine
Physicians Postgraduate Press.
-
11. Thyroid Augmentation of Mirtazapine: A Case Report
Physicians Postgraduate Press.
-
12. Mirtazapine-Associated Withdrawal Symptoms: A Case Report
Physicians Postgraduate Press.